185 related articles for article (PubMed ID: 31031602)
1. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.
Minalyan A; Gabrielyan L; Pietra C; Taché Y; Wang L
Front Integr Neurosci; 2019; 13():13. PubMed ID: 31031602
[No Abstract] [Full Text] [Related]
2. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Karasawa H; Pietra C; Giuliano C; Garcia-Rubio S; Xu X; Yakabi S; Taché Y; Wang L
Neurogastroenterol Motil; 2014 Dec; 26(12):1771-82. PubMed ID: 25327342
[TBL] [Abstract][Full Text] [Related]
3. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
4. Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01.
Naitou K; Mamerto TP; Pustovit RV; Callaghan B; Rivera LR; Chan AJ; Ringuet MT; Pietra C; Furness JB
Neurogastroenterol Motil; 2015 Dec; 27(12):1764-71. PubMed ID: 26416336
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.
Chiorazzi A; Wozniak KM; Rais R; Wu Y; Gadiano AJ; Farah MH; Liu Y; Canta A; Alberti P; Rodriguez-Menendez V; Meregalli C; Fumagalli G; Monza L; Pozzi E; Vornov JJ; Polydefkis M; Pietra C; Slusher BS; Cavaletti G
Eur J Pharmacol; 2018 Dec; 840():89-103. PubMed ID: 30268665
[TBL] [Abstract][Full Text] [Related]
6. The ghrelin agonist, HM01 activates central vagal and enteric cholinergic neurons and reverses gastric inflammatory and ileus responses in rats.
Yuan PQ; Wu SV; Wang L; Taché Y
Neurogastroenterol Motil; 2023 May; 35(5):e14561. PubMed ID: 36942655
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Central versus Peripheral Gastrointestinal Prokinetic Activity of Two Novel Ghrelin Mimetics.
Mohammadi EN; Pietra C; Giuliano C; Fugang L; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2019 Jan; 368(1):116-124. PubMed ID: 30377215
[TBL] [Abstract][Full Text] [Related]
8. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
9. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
10. Locus coeruleus is involved in weight loss in a rat model of Parkinson's disease: an effect reversed by deep brain stimulation.
Guimarães J; Moura E; Silva E; Aguiar P; Garrett C; Vieira-Coelho MA
Brain Stimul; 2013 Nov; 6(6):845-55. PubMed ID: 23849716
[TBL] [Abstract][Full Text] [Related]
11. Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia.
Ranjit R; Van Remmen H; Ahn B
Antioxidants (Basel); 2022 Nov; 11(12):. PubMed ID: 36552566
[TBL] [Abstract][Full Text] [Related]
12. The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).
Tu L; Lu Z; Ngan MP; Lam FFY; Giuliano C; Lovati E; Pietra C; Rudd JA
Br J Pharmacol; 2020 Apr; 177(7):1635-1650. PubMed ID: 31722444
[TBL] [Abstract][Full Text] [Related]
13. Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT
Rudd JA; Chan SW; Ngan MP; Tu L; Lu Z; Giuliano C; Lovati E; Pietra C
Front Pharmacol; 2018; 9():869. PubMed ID: 30127745
[TBL] [Abstract][Full Text] [Related]
14. Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle.
Kamińska K; Lenda T; Konieczny J; Czarnecka A; Lorenc-Koci E
Pharmacol Rep; 2017 Oct; 69(5):985-994. PubMed ID: 28843848
[TBL] [Abstract][Full Text] [Related]
15. Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA.
Gomes FA; Flores RA; Bruxel MA; da Silva FN; Moreira ELG; Zoccal DB; Prediger RD; Rafacho A
Front Neurosci; 2018; 12():1020. PubMed ID: 30686986
[TBL] [Abstract][Full Text] [Related]
16. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
17. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
Sharma S; Taliyan R; Singh S
Behav Brain Res; 2015 Sep; 291():306-314. PubMed ID: 26048426
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
20. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W
Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
